Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FP6ZW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,945
Award facts
- Contract value 100% obligated
- $4,944.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,944.93 by the Defense Logistics Agency (DLA) on August 12, 2025. The contract, which has no set-aside designation, covers the delivery of Entyvio 300 mg vials to support Department of Defense healthcare operations, with an ultimate completion date of September 3, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent performance on DLA delivery orders covering an extensive portfolio of medications and medical consumables, including prescription drugs, biologics, vaccines, and specialty pharmaceutical products. The company's woman-owned small business status and demonstrated capability in pharmaceutical distribution to military healthcare systems have positioned it as a preferred vendor for the DLA's pharmaceutical procurement needs across multiple therapeutic categories and product lines.
Quick answers
Who was awarded contract SPE2DB25FP6ZW?
SPE2DB25FP6ZW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FP6ZW worth?
The government has obligated $4,945 on SPE2DB25FP6ZW.
Is contract SPE2DB25FP6ZW an order under another contract?
Yes. SPE2DB25FP6ZW is a delivery order under SPE2DB22D9311, an indefinite delivery contract.
Was contract SPE2DB25FP6ZW competed?
The extent of competition for SPE2DB25FP6ZW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award